Search Results

LONG-TERM QUALITY-OF-LIFE AND PATIENT-REPORTED IMPROVEMENTS WITH GARADACIMAB FOR HEREDITARY ANGIOEDEMA: PHASE 3 OPEN-LABEL EXTENSION STUDY

• Authors : Braverman, J.; Chapdelaine, H.; Sitz, K.

• Source: Annals of Allergy, Asthma & Immunology; November 2023, Vol. 131 Issue: 5, Number 5 Supplement 1 pS39-S39, 1p

Record details

Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair®).

• Authors : Hughes, J. D. M.; Olynyc, T.; Chapdelaine, H.

Subjects: SKIN mast cell disease; IMMUNOLOGIC diseases; URTICARIA pigmentosa

• Source: Clinical & Experimental Dermatology. Jul2018, Vol. 43 Issue 5, p573-576. 4p. 1 Color Photograph, 1 Graph.

Record details

Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair®).

• Authors : Hughes, J. D. M.; Olynyc, T.; Chapdelaine, H.

Subjects: SKIN mast cell disease; IMMUNOLOGIC diseases; URTICARIA pigmentosa

• Source: Clinical & Experimental Dermatology; Jul2018, Vol. 43 Issue 5, p573-576, 4p, 1 Color Photograph, 1 Graph

Record details

SCIg vs IVIg: Let's Give Patients the Choice!

• Authors : Samaan, K.; Levasseur, M.; Decaluwe, H.

Subjects: IMMUNOGLOBULINS; IMMUNOLOGICAL deficiency syndrome treatment; IMMUNOLOGICAL deficiency syndromes

• Source: Journal of Clinical Immunology; Aug2014, Vol. 34 Issue 6, p611-614, 4p

Record details

Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair®).

• Authors : Hughes, J. D. M.¹; Olynyc, T.²; Chapdelaine, H.³

Subjects: *SKIN mast cell disease; *IMMUNOLOGIC diseases; *URTICARIA pigmentosa

• Source: Clinical & Experimental Dermatology. Jul2018, Vol. 43 Issue 5, p573-576. 4p. 1 Color Photograph, 1 Graph.

Record details

Successful desensitization in a type VI mucopolysaccharidosis patient with probable IgE-mediated allergy to galsulfase [Naglazyme].

• Authors : Bégin P; Chapdelaine H; Lemyre E

• Source: Annals of Allergy, Asthma & Immunology; Jan2013, Vol. 110 Issue 1, p55-56, 2p

Record details

Experience with subcutaneous immunoglobulin therapy in two pediatric cases of immune thrombocytopenia purpura.

• Authors : Chapdelaine, H.; Decaluwe, H.; Levasseur, M. C.

Subjects: IMMUNOGLOBULINS

• Source: Allergy, Asthma & Clinical Immunology; 2012, Vol. 8 Issue Suppl 1, p1-1, 1p

Record details

Functional common gamma chain is not required for mast cell proliferation and survival.

• Authors : Chapdelaine, H.; Canioni, D.; De Saint-Basile, G.

Subjects: CELL proliferation; LYMPHOCYTES

• Source: Allergy, Asthma & Clinical Immunology; 2012, Vol. 8 Issue Suppl 1, p1-1, 1p

Record details

Pediatric Liver Transplantation And Food Allergy: Cyclosporine Compared To Tacrolimus Immunosuppression.

• Authors : Chapdelaine, H.; Lebel, M.; Paradis, L.

• Source: Journal of Allergy & Clinical Immunology; Feb2011 Supplement, Vol. 127 Issue 2, pAB30-AB30, 1p

Record details

Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair®).

• Authors : Hughes, J. D. M.; Olynyc, T.; Chapdelaine, H.

Subjects: SKIN mast cell disease; IMMUNOLOGIC diseases; URTICARIA pigmentosa

• Source: Clinical & Experimental Dermatology. Jul2018, Vol. 43 Issue 5, p573-576. 4p. 1 Color Photograph, 1 Graph.

Record details